Rhythm-control therapy for new-onset atrial fibrillation in critically ill patients: A post hoc analysis from the prospective multicenter observational AFTER-ICU study

Background: Sustained new-onset atrial fibrillation (AF) in the intensive care unit has been reported to be associated with poor outcomes. However, in critical illness, whether rhythm-control therapy can achieve sinus rhythm (SR) restoration is unknown. This study aimed to assess the impact of rhyth...

Full description

Bibliographic Details
Main Authors: Takuo Yoshida, Shigehiko Uchino, Yusuke Sasabuchi, Michihito Kyo, Takashi Igarashi, Haruka Inoue
Format: Article
Language:English
Published: Elsevier 2021-04-01
Series:International Journal of Cardiology: Heart & Vasculature
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2352906721000300
_version_ 1819136136506769408
author Takuo Yoshida
Shigehiko Uchino
Yusuke Sasabuchi
Michihito Kyo
Takashi Igarashi
Haruka Inoue
author_facet Takuo Yoshida
Shigehiko Uchino
Yusuke Sasabuchi
Michihito Kyo
Takashi Igarashi
Haruka Inoue
author_sort Takuo Yoshida
collection DOAJ
description Background: Sustained new-onset atrial fibrillation (AF) in the intensive care unit has been reported to be associated with poor outcomes. However, in critical illness, whether rhythm-control therapy can achieve sinus rhythm (SR) restoration is unknown. This study aimed to assess the impact of rhythm-control therapy on SR restoration for new-onset AF in critically ill patients. Methods: This post-hoc analysis of a prospective multicenter observational study involving 32 Japan intensive care units compared patients with and without rhythm-control therapy for new-onset atrial fibrillation (AF) and conducted a multivariable analysis using Cox proportional hazards regression analysis including rhythm-control therapy as a time-varying covariate for SR restoration. Results: Of 423 new-onset AF patients, 178 patients (42%) underwent rhythm-control therapy. Among those patients, 131 (31%) underwent rhythm-control therapy within 6 h after AF onset. Magnesium sulphate was the most frequently used rhythm-control drug. The Cox proportional hazards model for SR restoration showed that rhythm-control therapy had a significant positive association with SR restoration (adjusted hazard ratio: 1.46; 95% confidence interval: 1.16–1.85). However, the rhythm-control group had numerically higher hospital mortality than the non-rhythm-control group (31% vs. 23%, p = 0.09). Conclusions: Rhythm-control therapy for new-onset AF in critically ill patients was associated with SR restoration. However, patients with rhythm-control therapy had poorer prognosis, possibly due to selection bias. These findings may provide important insight for the design and feasibility of interventional studies assessing rhythm-control therapy in new-onset AF.
first_indexed 2024-12-22T10:30:11Z
format Article
id doaj.art-2c924997ac2b4dc6a1df73b6f1d895ac
institution Directory Open Access Journal
issn 2352-9067
language English
last_indexed 2024-12-22T10:30:11Z
publishDate 2021-04-01
publisher Elsevier
record_format Article
series International Journal of Cardiology: Heart & Vasculature
spelling doaj.art-2c924997ac2b4dc6a1df73b6f1d895ac2022-12-21T18:29:20ZengElsevierInternational Journal of Cardiology: Heart & Vasculature2352-90672021-04-0133100742Rhythm-control therapy for new-onset atrial fibrillation in critically ill patients: A post hoc analysis from the prospective multicenter observational AFTER-ICU studyTakuo Yoshida0Shigehiko Uchino1Yusuke Sasabuchi2Michihito Kyo3Takashi Igarashi4Haruka Inoue5Intensive Care Unit, Department of Anesthesiology, Jikei University School of Medicine, Tokyo, Japan; Corresponding author.Intensive Care Unit, Department of Anesthesiology, Jikei University School of Medicine, Tokyo, JapanData Science Center, Jichi Medical University, Tochigi, JapanDepartment of Emergency and Critical Care Medicine, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, JapanDepartment of Trauma and Critical Care Medicine, School of Medicine, Kyorin University, Tokyo, JapanDepartment of Anesthesiology and Intensive Care Medicine, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, JapanBackground: Sustained new-onset atrial fibrillation (AF) in the intensive care unit has been reported to be associated with poor outcomes. However, in critical illness, whether rhythm-control therapy can achieve sinus rhythm (SR) restoration is unknown. This study aimed to assess the impact of rhythm-control therapy on SR restoration for new-onset AF in critically ill patients. Methods: This post-hoc analysis of a prospective multicenter observational study involving 32 Japan intensive care units compared patients with and without rhythm-control therapy for new-onset atrial fibrillation (AF) and conducted a multivariable analysis using Cox proportional hazards regression analysis including rhythm-control therapy as a time-varying covariate for SR restoration. Results: Of 423 new-onset AF patients, 178 patients (42%) underwent rhythm-control therapy. Among those patients, 131 (31%) underwent rhythm-control therapy within 6 h after AF onset. Magnesium sulphate was the most frequently used rhythm-control drug. The Cox proportional hazards model for SR restoration showed that rhythm-control therapy had a significant positive association with SR restoration (adjusted hazard ratio: 1.46; 95% confidence interval: 1.16–1.85). However, the rhythm-control group had numerically higher hospital mortality than the non-rhythm-control group (31% vs. 23%, p = 0.09). Conclusions: Rhythm-control therapy for new-onset AF in critically ill patients was associated with SR restoration. However, patients with rhythm-control therapy had poorer prognosis, possibly due to selection bias. These findings may provide important insight for the design and feasibility of interventional studies assessing rhythm-control therapy in new-onset AF.http://www.sciencedirect.com/science/article/pii/S2352906721000300New-onset atrial fibrillationCritical illnessRhythm-control therapy: sinus rhythm restoration
spellingShingle Takuo Yoshida
Shigehiko Uchino
Yusuke Sasabuchi
Michihito Kyo
Takashi Igarashi
Haruka Inoue
Rhythm-control therapy for new-onset atrial fibrillation in critically ill patients: A post hoc analysis from the prospective multicenter observational AFTER-ICU study
International Journal of Cardiology: Heart & Vasculature
New-onset atrial fibrillation
Critical illness
Rhythm-control therapy: sinus rhythm restoration
title Rhythm-control therapy for new-onset atrial fibrillation in critically ill patients: A post hoc analysis from the prospective multicenter observational AFTER-ICU study
title_full Rhythm-control therapy for new-onset atrial fibrillation in critically ill patients: A post hoc analysis from the prospective multicenter observational AFTER-ICU study
title_fullStr Rhythm-control therapy for new-onset atrial fibrillation in critically ill patients: A post hoc analysis from the prospective multicenter observational AFTER-ICU study
title_full_unstemmed Rhythm-control therapy for new-onset atrial fibrillation in critically ill patients: A post hoc analysis from the prospective multicenter observational AFTER-ICU study
title_short Rhythm-control therapy for new-onset atrial fibrillation in critically ill patients: A post hoc analysis from the prospective multicenter observational AFTER-ICU study
title_sort rhythm control therapy for new onset atrial fibrillation in critically ill patients a post hoc analysis from the prospective multicenter observational after icu study
topic New-onset atrial fibrillation
Critical illness
Rhythm-control therapy: sinus rhythm restoration
url http://www.sciencedirect.com/science/article/pii/S2352906721000300
work_keys_str_mv AT takuoyoshida rhythmcontroltherapyfornewonsetatrialfibrillationincriticallyillpatientsaposthocanalysisfromtheprospectivemulticenterobservationalaftericustudy
AT shigehikouchino rhythmcontroltherapyfornewonsetatrialfibrillationincriticallyillpatientsaposthocanalysisfromtheprospectivemulticenterobservationalaftericustudy
AT yusukesasabuchi rhythmcontroltherapyfornewonsetatrialfibrillationincriticallyillpatientsaposthocanalysisfromtheprospectivemulticenterobservationalaftericustudy
AT michihitokyo rhythmcontroltherapyfornewonsetatrialfibrillationincriticallyillpatientsaposthocanalysisfromtheprospectivemulticenterobservationalaftericustudy
AT takashiigarashi rhythmcontroltherapyfornewonsetatrialfibrillationincriticallyillpatientsaposthocanalysisfromtheprospectivemulticenterobservationalaftericustudy
AT harukainoue rhythmcontroltherapyfornewonsetatrialfibrillationincriticallyillpatientsaposthocanalysisfromtheprospectivemulticenterobservationalaftericustudy